1. Market Research
  2. > Healthcare
  3. > Medical Device Market Trends
  4. > In Vitro Diagnostics

In-Vitro Testing Equipment Industry: Comprehensive Market Analysis

  • Currently 3/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
6 votes

In Vitro Diagnostics

The process of testing and analyzing human samples, such as blood or tissue to diagnose infections and health conditions is called in vitro diagnostics (IVDs). The purpose of IVD tests is to assess the health status of a patient. These tests are performed outside of the body. Checking blood for signs of infections, tests for infectious disease, such as HIV or hepatitis, cholesterol, anaemia and for various genetic diseases or conditions are common uses of IVDs.

Federal agencies involved in the regulation of IVDs in the USA include the Food and Drug Administration and the Centers for Medicare & Medicaid Services. Roche Diagnostics Limited, Abbott Laboratories, Inc. and Siemens Healthcare are some of the major players in the in vitro market.

Key Market Segments

IVDs of the types mentioned below are used in health care in numerous ways and at various points.

Clinical laboratory testing: These tests are generally prescribed by the physician. The information obtained assists in the evaluation of overall health, in disease diagnosis and in the establishment of appropriate treatment. Clinical laboratory tests influence approximately 70% of healthcare decisions.

Point-of-care diagnostics: This kind of test is carried out by healthcare professionals, such as doctors, nurses or paramedics. These tests do not require specialist laboratory facilities and can normally deliver results very quickly. This type of testing is used for providing insights for a preliminary diagnosis or for managing patient conditions.

Self-testing: These tests are designed for patients or individuals to use themselves. They do not require any specialist facilities, and the user can usually interpret the information. The most familiar are bloodsugar tests for managing diabetes and home pregnancy tests, but a variety of other tests is becoming widely available. HIV self-testing is increasingly being sought and offered globally.

Regional Market Shares

Increasing emphasis on the early detection of diseases and infections is likely to drive the global demand for IVDs to about $75 billion by 2020. The USA, Europe and Asia account for the largest share of the IVD market.

The USA is one of the largest markets for IVDs in the world, with a market value of more than $24 billion. Professional point-of-care diagnostics is the largest segment in the USA. Population aging and expansion of the insured population resulting from the Affordable Care Act are likely to drive growth of the US IVD market to more than $28 billion in the near future.

The healthcare system in most of Europe depends on government funding. As a result the IVD market in Europe has recently witnessed slow growth as governments have cut costs. Increasing incidence of serious diseases has, however, driven up the market; the European market for cancer IVD, for instance, was worth more than $1.5 billion in 2015.

Asia’s IVD market is estimated to be worth more than $17 billion. Corporate firms offering annual health checks for their employees and insurance companies conducting pre-insurance policy checks are fuelling the industry. Increasing levels of chronic diseases, patient awareness, patient self testing and significant urban populations are driving the uptake of various IVD tests and creating opportunities for market expansion.

Read more »

24/7 Customer Support

Talk to Sam

+1 646 893 5945

12 Reports
Company, Company Financials, Forecast
92 Statistics
Market Size, Company Financials, Finance
21 Reports
Company, Demand, Company Financials
61 Statistics
Market Size, Finance, Demand
8 Reports
Market Size, Demand, Company Financials
40 Statistics
Market Size, Demand, Company Financials
5 Reports
Demand, Market Size, Supply
35 Statistics
Market Size, Finance, Company Financials
5 Reports
Demographic, Company, Company Financials
10 Statistics
Demographic, Environment, Market Size
4 Reports
Demographic, Company Financials, Market Size
13 Statistics
Demographic, Environment, Finance
4 Reports
Company, Company Financials, Company Operations
14 Statistics
Finance, Company Financials, Company
3 Reports
Demand, Market Size, Company
4 Statistics
Finance, Company Financials, Demand
Search in In Vitro Diagnostics Industry (About 900 reports)
Parent industry: Medical Device
Related industries: Diagnostic Imaging, Cardiovascular Devices, Orthopedics, Respiratory Device, Surgical Equipment, Dialysis Device, Endoscopic Device, Patient Monitoring

About 9500 reports

Purchase Reports From Reputable Market Research Publishers
(From $ 149 - $ 52500)

Cancer Biomarkers Market by Type, Cancer Type, Profiling Technology, Application - Global Forecast to 2022

Cancer Biomarkers Market: Global Forecast until 2022

  • $ 7150
  • Industry report
  • October 2017
  • by MarketsandMarkets

“Global cancer biomarkers market projected to grow at CAGR of 12.2%”The global cancer biomarkers market is projected to reach USD 20.48 billion by 2022 from USD 11.53 billion in 2017, at a CAGR of ...

Clinical Laboratory Services Market: Global Forecasts u ... $ 5650 December 2017

Kidney/Renal Function Test Market: Global Forecast unti ... $ 5650 December 2017

Tissue Diagnostics Market: Global Forecast until 2022 $ 5650 November 2017

3D Cell Culture Market: Global Forecast until 2022 $ 5650 November 2017

Life Science Instrumentation Market: Global Forecast un ... $ 5650 September 2017

Research Antibodies Market: Global Forecast until 2022 $ 5650 August 2017

Single-cell Analysis Market: Global Forecasts until 202 ... $ 5650 June 2017

Mycoplasma Testing Market: Global Forecast until 2022 $ 5650 June 2017

Gas Chromatography Market: Global Forecast until 2022 $ 5650 May 2017

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.